FDA
approval
· 2015-11-05
FDA Approved: IOPIDINE 1% — Supplemental Application (Harrow Eye, LLC)
Summary
The FDA approved a supplemental application to market IOPIDINE 1% (apraclonidine hydrochloride ophthalmic solution) under Harrow Eye, LLC. This introduces a new…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IOPIDINE 1% (APRACLONIDINE HYDROCHLORIDE OPHTHALMIC SOLUTION)